Biotech on life support
July 16th, 2007 | Comments Off
When QLT Inc. announced last week that a U.S. court had ordered the Vancouver-based biotechnology company to pay royalties for all past, present and future sales of its marquee drug to a Massachusetts specialty hospital, its stock, naturally, took a hit.
Original post by Canada.com
(click on the author link above to see full post)